In pancreatic cancer, the interaction between DDR1 and Transmembrane-4-L-six-family-1 (TM4SF1) increases the expression of MMP2 and MMP9, enzymes that degrade the basement membrane and disrupt tissue barriers, facilitating cancer cell invasion and metastasis [81]. Here, DDR1 is linked to pancreatic neoplasm.